Localization of major gangliosides in the PNS: Implications for immune neuropathies

Brain

Volumn 125, Issue 11, 2002, Pages 2491-2506

  Gong, Y ^a,b   Tagawa, Y ^a   Lunn, M P T ^c   Laroy, W ^a   Heffer Lauc, M ^d   Li, C Y ^b   Griffin, J W ^a   Schnaar, R L ^a   Sheikh, Kazim ^a,e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

AMAN; Anti ganglioside antibodies; Guillain Barr syndrome; Immune neuropathies; Sensory ataxic neuropathy

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GT 1B; MONOCLONAL ANTIBODY; MYELIN; NERVE PROTEIN;

ACUTE MOTOR AXONAL NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROSS REACTION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNE NEUROPATHY; MOTOR NERVE; MOTOR NEUROPATHY; MOUSE; NERVE INJURY; NEUROPATHY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SENSORY NERVE; SENSORY NEUROPATHY; SPINAL GANGLION; SYMPTOMATOLOGY; TISSUE DISTRIBUTION;

EID: 0036846833     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf258     Document Type: Article

References (80)

1. Apostolski S, Sadiq SA, Hays A, Corbo M, Suturkova-Milsoevic L, Chaliff P, et al. Identification of Gal(beta1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 1994; 38: 134-41.
2. Ariga T, Miyatake T, Yu RK. Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders. [Review]. J Neurosci Res 2001; 65: 363-70.
3. Buchwald B, Toyka KV, Zielasek J, Weishaupt A, Schweiger S, Dudel J. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barre syndrome: A macro-patch-clamp study. Ann Neurol 1998; 44: 913-22.
4. Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, et al. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol 1996; 39: 539-43.
5. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQlb is a possible marker of Miller Fisher syndrome. Ann Neurol 1992; 31: 677-9.
6. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: Clinical and immunohistochemical studies. Neurology 1993; 43: 1911-7.
7. Collins BE, Yang LJ, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, et al. Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem 1997; 272: 1248-55.
8. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1 and Gal(beta1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993; 43: 809-14.
9. Crossin KL, Hoffman S, Tan SS, Edelman GM. Cytotactin and its proteoglycan ligand mark structural and functional boundaries in somatosensory cortex of the early postnatal mouse. Dev Biol 1989; 136: 381-92.
10. De Angelis MV, Di Muzio A, Lupo S, Gambi D, Uncini A, Lugaresi A. Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier. J Neuroimmunol 2001; 121: 79-82.
11. Eurelings M, Ang CW, Notermans NC, Van Doom PA, Jacobs BC, Van den Berg LH. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 2001; 57: 1909-12.
12. Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, et al. Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 1999; 104: 697-708.
13. Haberberger RV, Bodenbenner M. Immunohistochemical localization of muscarinic receptors (M2) in the rat skin. Cell Tissue Res 2000; 300: 389-96.
14. Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, et al. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 1998; 81: 116-26.
15. Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K. Anti-GalNAc-GD1a antibody-associated Guillain-Barre syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Ann Neurol 1999; 45: 758-68.
16. Hartung HP, Willison H, Jung S, Pette M, Toyka KV, Giegerich G. Autoimmune responses in peripheral nerve. [Review]. Springer Semin Immunopathol 1996; 18: 97-123.
17. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barre syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118: 597-605.
18. Ho TW, Willison HJ, Nachamkin I Li CY, Veitch J, Ung H, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol 1999; 45: 168-73.
19. Hoffman S, Crossin KL, Edelman GM. Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J Cell Biol 1988; 106: 519-32.
20. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases. Ann Neurol 1998; 44: 47-59.
21. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. [Review]. J Neuroimmunol 1999; 100: 74-97.
22. Ikami T, Ishida H, Kiso M. Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs. Methods Enzymol 2000; 311: 547-68.
23. Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, et al. Serum antibodies to gangliosides in Guillain-Barre syndrome. Ann Neurol 1988a; 23: 440-7.
24. Ilyas AA, Li SC, Chou DK, Li YT, Dalakas MC, et al. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J Biol Chem 1988b; 263: 4369-73.
25. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I. Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 2000; 123: 116-24.
26. Kitchener PD, Lapiz MD, Wilson P, Snow PJ. Transganglionic labelling of primary sensory afferents in the rat lumbar spinal cord: Comparison between wheatgerm agglutinin and the I- B4 isolectin from Bandeiraea simplicifolia. J Neurocytol 1994; 23: 745-57.
27. Kusunoki S. Antiglycolipid antibodies in Guillain-Barre syndrome and autoimmune neuropathies. [Review]. Am J Med Sci 2000; 319: 234-9.
28. Kusunoki S, Chiba A, Tai T, Kanazawa I. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 1993; 16: 752-6.
29. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996; 39: 424-31.
30. Kusunoki S, Mashiko H, Mochizuki N, Chiba A, Arita M, Hitoshi S, et al. Binding of antibodies against GM1 and GD1b in human peripheral nerve. Muscle Nerve 1997; 20: 840-5.
31. Kusunoki S, Hitoshi S, Kaida K, Arita M, Kanazawa I. Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy. Ann Neurol 1999; 45: 400-3.
32. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 1998; 44: 202-8.
33. Ladisch S, Gillard B. A solvent partition method for microscale ganglioside purification. Anal Biochem 1985; 146: 220-31.
34. Liu Y, Wada R, Kawai H Sango K, Deng C, Tai T, et al. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 1999; 103: 497-505.
35. Lugaresi A, Ragno M, Torrieri F, Di Guglielmo G, Fermani P, Uncini A. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J Neurol Sci 1997; 147: 193-200.
36. Lunn MP, Johnson LA, Fromholt SE, Itonori S, Huang J, Vyas AA, et al. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization. J Neurochem 2000; 75: 404-12.
37. Molander M, Berthold C-H, Persson H, Andersson K, Fredman P. Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody. J Neurocytol 1997; 26: 101-111.
38. Odaka M, Yuki N, Yoshino H, Kiso M, Ishida H, Hirata K. Antibodies to GD1alpha and to GQ1beta in Guillain-Barre syndrome and the related disorders. J Neurol Sci 1999; 165: 126-32.
39. Ogawa-Goto K, Abe T. Gangliosides and glycosphingolipids of peripheral nervous system myelins - A minireview. [Review]. Neurochem Res 1998; 23: 305-10.
40. Ogawa-Goto K, Funamoto N, Abe T, Nagashima K. Different ceramide compositions of gangliosides between human motor and sensory nerves. J Neurochem 1990; 55: 1486-93.
41. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barre syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48: 624-31.
42. Ogino M, Tatum AH, Latov N. Affinity studies of human anti-MAG antibodies in neuropathy. J Neuroimmunol 1994; 52: 41-6.
43. O'Leary CP, Willison HJ. Autoimmune ataxic neuropathies (sensory ganglionopathies). [Review]. Curr Opin Neurol 1997; 10: 366-70.
44. O'Leary CP, Willison HJ. The role of antiglycolipid antibodies in peripheral neuropathies. [Review]. Curr Opin Neurol 2000; 13: 583-8.
45. Pan CL, Yuki N, Koga M, Chiang MC, Hsieh ST. Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology 2001; 57: 1316-8.
46. Paparounas K, O'Hanlon GM, O'Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 1999; 122: 807-16.
47. Pestronk A, Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997; 49: 1289-92.
48. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988; 24: 73-8.
49. Plomp JJ, Molenaar PC, O'Hanlon GM, Jacobs BC, Veitch J, Daha MR, et al. Miller Fisher anti-GQlb antibodies: Alpha-latrotoxin-like effects on motor end plates. Ann Neurol 1999; 45: 189-99.
50. Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. [Review]. Muscle Nerve 1999; 22: 800-22.
51. Rees JH, Gregson NA, Hughes RA. Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995; 38: 809-16.
52. Rieger F, Daniloff JK, Pincon-Raymond M, Crossin KL, Grumet M, Edelman GM. Neuronal cell adhesion molecules and cytotactin are colocalized at the node of Ranvier. J Cell Biol 1986; 103: 379-91.
53. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller Fisher variant of Guillain-Barre syndrome and neurotransmitter release. Lancet 1994; 343: 454-5.
54. Roberts M, Willison HJ, Vincent A, Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995; 38: 111-8.
55. Schnaar RL. Isolation of glycosphingolipids. Methods Enzymol 1994; 230: 348-70.
56. Schnaar RL, Fromholt SE, Gong Y, Vyas AA, Laroy W, Wayman DM, et al. Immunoglobulin g-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem 2002; 302: 276-84.
57. Schnaar RL, Needham LK. Thin-layer chromatography of glyosphingolipids. Methods Enzymol 1994; 230: 371-89.
58. Sheikh KA, Deerinck TJ, Ellisman MH, Griffin JW. The distribution of ganglioside-like moieties in peripheral nerves. Brain 1999; 122: 449-60.
59. Shuman S, Hardy M, Pleasure D. Peripheral nervous system myelin and Schwann cell glycoproteins: Identification by lectin binding and partial purification of a peripheral nervous system myelin-specific 170,000 molecular weight glycoprotein. J Neurochem 1983; 41: 1277-85.
60. Silverman JD, Kruger L. Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: Relation of lectin reactivity to peptide and enzyme markers. J Neurocytol 1990; 19: 789-801.
61. Stefansson K, Marton LS, Dieperink ME, Molnar GK, Schlaepfer WW, Helgason CM. Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science 1985; 228: 1117-9.
62. Susuki K, Yuki N, Hirata K. Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody. J Neuroimmunol 2001; 112: 181-7.
63. Svennerholm L. Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res 1994; 101: XI-XIV.
64. Svennerholm L, Bostrom K, Fredman P, Jungbjer B, Mansson JE, Rynmark BM. Membrane lipids of human peripheral nerve and spinal cord. Biochim Biophys Acta 1992; 1128: 1-7.
65. Svennerholm L, Bostrom K, Fredman P, Jungbjer B, Lekman A, Mansson JE, et al. Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta 1994; 1214: 115-23.
66. Walsh FS, Cronin M, Koblar S, Doherty P, Winer K, Leon A, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barre syndrome. J Neuroimmunol 1991; 34: 43-51.
67. Willison HJ, Veitch J. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol 1994; 50: 159-65.
68. Willison HJ, Veitch J, Patterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993; 56: 204-206.
69. Willison HJ, Almemar A, Veitch J, Thrush D. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 1994; 44: 2395-7.
70. Yoshino H. Distribution of gangliosides in the nervous tissues recognized by axonal form of Guillain-Barre syndrome. [Japanese]. Neuroimmunology 1997; 5: 174-5.
71. Yu RK, Saito M. Structure and localization of gangliosides. In: Margolis RU, Margolis RK, editors. Neurobiology of glycoconjugates. New York: Plenum Press; 1989. p. 1-42.
72. Yuki N. Anti-ganglioside antibody and neuropathy: Review of our research. [Review]. J Peripher Nerv Syst 1998; 3: 3-18.
73. Yuki N. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barre syndrome. Cell Mol Life Sci 2000; 57: 527-33.
74. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990; 40: 1900-2.
75. Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, et al. Association of IgG anti-GD1a antibody with severe Guillain-Barre syndrome. Muscle Nerve 1993a; 16: 642-7.
76. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 1993b; 43: 414-7.
77. Yuki N, Ichihashi Y, Taki T. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barre syndrome. J Neuroimmunol 1995; 60: 161-4.
78. Yuki N, Taki T, Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barre syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 1996; 71: 155-61.
79. Yuki N, Ho TW, Tagawa Y, Koga M, Li CY, Hirata K, et al. Autoantibodies to GM1b and GalNAc-GD1a: Relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci 1999; 164: 134-8.
80. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001; 49: 712-20.